0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biological Method based Dodecanoic Acid (DC12) Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-21W17383
Home | Market Reports | Business & Industrial| Chemicals Industry
Global Biological Method based Dodecanoic Acid DC12 Market Research Report 2024
BUY CHAPTERS

Global Biological Method based Dodecanoic Acid (DC12) Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-21W17383
Report
October 2025
Pages:148
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Biological Method based Dodecanoic Acid (DC12) Market

The global Biological Method based Dodecanoic Acid (DC12) market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Polyamide and Polyester Resin accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Biological Method based Dodecanoic Acid (DC12) leading manufacturers including Cathay Biotech, INVISTA, Evonik Industries, UBE Industries, Palmary Chemical, Henan Junheng Industrial Group, Shandong Guangtong New Materials, Hengli Biological New Materials, etc., dominate supply; the top five capture approximately % of global revenue, with Cathay Biotech leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Biological Method based Dodecanoic Acid (DC12) market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Biological Method based Dodecanoic Acid (DC12) Market Report

Report Metric Details
Report Name Biological Method based Dodecanoic Acid (DC12) Market
Segment by Type
  • ≥98.5%
  • ≥95%
Segment by Application
Production by Region
  • North America
  • Europe
  • China
  • Japan
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Cathay Biotech, INVISTA, Evonik Industries, UBE Industries, Palmary Chemical, Henan Junheng Industrial Group, Shandong Guangtong New Materials, Hengli Biological New Materials
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Biological Method based Dodecanoic Acid (DC12) study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
  • Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
  • Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Biological Method based Dodecanoic Acid (DC12) Market report?

Ans: The main players in the Biological Method based Dodecanoic Acid (DC12) Market are Cathay Biotech, INVISTA, Evonik Industries, UBE Industries, Palmary Chemical, Henan Junheng Industrial Group, Shandong Guangtong New Materials, Hengli Biological New Materials

What are the Application segmentation covered in the Biological Method based Dodecanoic Acid (DC12) Market report?

Ans: The Applications covered in the Biological Method based Dodecanoic Acid (DC12) Market report are Polyamide and Polyester Resin, Metal Processing, Spices, Other

What are the Type segmentation covered in the Biological Method based Dodecanoic Acid (DC12) Market report?

Ans: The Types covered in the Biological Method based Dodecanoic Acid (DC12) Market report are ≥98.5%, ≥95%

Recommended Reports

Bio-based Polymers

Biological Chemicals

Bioscience Solutions

1 Study Coverage
1.1 Introduction to Biological Method based Dodecanoic Acid (DC12): Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Biological Method based Dodecanoic Acid (DC12) Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 ≥98.5%
1.2.3 ≥95%
1.3 Market Segmentation by Application
1.3.1 Global Biological Method based Dodecanoic Acid (DC12) Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Polyamide and Polyester Resin
1.3.3 Metal Processing
1.3.4 Spices
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Biological Method based Dodecanoic Acid (DC12) Revenue Estimates and Forecasts 2020-2031
2.2 Global Biological Method based Dodecanoic Acid (DC12) Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Biological Method based Dodecanoic Acid (DC12) Sales Estimates and Forecasts 2020-2031
2.4 Global Biological Method based Dodecanoic Acid (DC12) Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Biological Method based Dodecanoic Acid (DC12) Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Biological Method based Dodecanoic Acid (DC12) Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Biological Method based Dodecanoic Acid (DC12) Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 ≥98.5% Market Size by Manufacturers
4.5.2 ≥95% Market Size by Manufacturers
4.6 Global Biological Method based Dodecanoic Acid (DC12) Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Biological Method based Dodecanoic Acid (DC12) Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Biological Method based Dodecanoic Acid (DC12) Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Biological Method based Dodecanoic Acid (DC12) Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Biological Method based Dodecanoic Acid (DC12) Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Biological Method based Dodecanoic Acid (DC12) Sales and Revenue by Type (2020-2031)
7.4 North America Biological Method based Dodecanoic Acid (DC12) Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Biological Method based Dodecanoic Acid (DC12) Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Biological Method based Dodecanoic Acid (DC12) Sales and Revenue by Type (2020-2031)
8.4 Europe Biological Method based Dodecanoic Acid (DC12) Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Biological Method based Dodecanoic Acid (DC12) Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Biological Method based Dodecanoic Acid (DC12) Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Biological Method based Dodecanoic Acid (DC12) Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Biological Method based Dodecanoic Acid (DC12) Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Biological Method based Dodecanoic Acid (DC12) Sales and Revenue by Type (2020-2031)
10.4 Central and South America Biological Method based Dodecanoic Acid (DC12) Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Biological Method based Dodecanoic Acid (DC12) Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Biological Method based Dodecanoic Acid (DC12) Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Biological Method based Dodecanoic Acid (DC12) Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Biological Method based Dodecanoic Acid (DC12) Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Cathay Biotech
12.1.1 Cathay Biotech Corporation Information
12.1.2 Cathay Biotech Business Overview
12.1.3 Cathay Biotech Biological Method based Dodecanoic Acid (DC12) Product Models, Descriptions and Specifications
12.1.4 Cathay Biotech Biological Method based Dodecanoic Acid (DC12) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Cathay Biotech Biological Method based Dodecanoic Acid (DC12) Sales by Product in 2024
12.1.6 Cathay Biotech Biological Method based Dodecanoic Acid (DC12) Sales by Application in 2024
12.1.7 Cathay Biotech Biological Method based Dodecanoic Acid (DC12) Sales by Geographic Area in 2024
12.1.8 Cathay Biotech Biological Method based Dodecanoic Acid (DC12) SWOT Analysis
12.1.9 Cathay Biotech Recent Developments
12.2 INVISTA
12.2.1 INVISTA Corporation Information
12.2.2 INVISTA Business Overview
12.2.3 INVISTA Biological Method based Dodecanoic Acid (DC12) Product Models, Descriptions and Specifications
12.2.4 INVISTA Biological Method based Dodecanoic Acid (DC12) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 INVISTA Biological Method based Dodecanoic Acid (DC12) Sales by Product in 2024
12.2.6 INVISTA Biological Method based Dodecanoic Acid (DC12) Sales by Application in 2024
12.2.7 INVISTA Biological Method based Dodecanoic Acid (DC12) Sales by Geographic Area in 2024
12.2.8 INVISTA Biological Method based Dodecanoic Acid (DC12) SWOT Analysis
12.2.9 INVISTA Recent Developments
12.3 Evonik Industries
12.3.1 Evonik Industries Corporation Information
12.3.2 Evonik Industries Business Overview
12.3.3 Evonik Industries Biological Method based Dodecanoic Acid (DC12) Product Models, Descriptions and Specifications
12.3.4 Evonik Industries Biological Method based Dodecanoic Acid (DC12) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Evonik Industries Biological Method based Dodecanoic Acid (DC12) Sales by Product in 2024
12.3.6 Evonik Industries Biological Method based Dodecanoic Acid (DC12) Sales by Application in 2024
12.3.7 Evonik Industries Biological Method based Dodecanoic Acid (DC12) Sales by Geographic Area in 2024
12.3.8 Evonik Industries Biological Method based Dodecanoic Acid (DC12) SWOT Analysis
12.3.9 Evonik Industries Recent Developments
12.4 UBE Industries
12.4.1 UBE Industries Corporation Information
12.4.2 UBE Industries Business Overview
12.4.3 UBE Industries Biological Method based Dodecanoic Acid (DC12) Product Models, Descriptions and Specifications
12.4.4 UBE Industries Biological Method based Dodecanoic Acid (DC12) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 UBE Industries Biological Method based Dodecanoic Acid (DC12) Sales by Product in 2024
12.4.6 UBE Industries Biological Method based Dodecanoic Acid (DC12) Sales by Application in 2024
12.4.7 UBE Industries Biological Method based Dodecanoic Acid (DC12) Sales by Geographic Area in 2024
12.4.8 UBE Industries Biological Method based Dodecanoic Acid (DC12) SWOT Analysis
12.4.9 UBE Industries Recent Developments
12.5 Palmary Chemical
12.5.1 Palmary Chemical Corporation Information
12.5.2 Palmary Chemical Business Overview
12.5.3 Palmary Chemical Biological Method based Dodecanoic Acid (DC12) Product Models, Descriptions and Specifications
12.5.4 Palmary Chemical Biological Method based Dodecanoic Acid (DC12) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Palmary Chemical Biological Method based Dodecanoic Acid (DC12) Sales by Product in 2024
12.5.6 Palmary Chemical Biological Method based Dodecanoic Acid (DC12) Sales by Application in 2024
12.5.7 Palmary Chemical Biological Method based Dodecanoic Acid (DC12) Sales by Geographic Area in 2024
12.5.8 Palmary Chemical Biological Method based Dodecanoic Acid (DC12) SWOT Analysis
12.5.9 Palmary Chemical Recent Developments
12.6 Henan Junheng Industrial Group
12.6.1 Henan Junheng Industrial Group Corporation Information
12.6.2 Henan Junheng Industrial Group Business Overview
12.6.3 Henan Junheng Industrial Group Biological Method based Dodecanoic Acid (DC12) Product Models, Descriptions and Specifications
12.6.4 Henan Junheng Industrial Group Biological Method based Dodecanoic Acid (DC12) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Henan Junheng Industrial Group Recent Developments
12.7 Shandong Guangtong New Materials
12.7.1 Shandong Guangtong New Materials Corporation Information
12.7.2 Shandong Guangtong New Materials Business Overview
12.7.3 Shandong Guangtong New Materials Biological Method based Dodecanoic Acid (DC12) Product Models, Descriptions and Specifications
12.7.4 Shandong Guangtong New Materials Biological Method based Dodecanoic Acid (DC12) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Shandong Guangtong New Materials Recent Developments
12.8 Hengli Biological New Materials
12.8.1 Hengli Biological New Materials Corporation Information
12.8.2 Hengli Biological New Materials Business Overview
12.8.3 Hengli Biological New Materials Biological Method based Dodecanoic Acid (DC12) Product Models, Descriptions and Specifications
12.8.4 Hengli Biological New Materials Biological Method based Dodecanoic Acid (DC12) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Hengli Biological New Materials Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Biological Method based Dodecanoic Acid (DC12) Industry Chain
13.2 Biological Method based Dodecanoic Acid (DC12) Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Biological Method based Dodecanoic Acid (DC12) Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Biological Method based Dodecanoic Acid (DC12) Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Biological Method based Dodecanoic Acid (DC12) Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Biological Method based Dodecanoic Acid (DC12) Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
List of Tables
 Table 1. Global Biological Method based Dodecanoic Acid (DC12) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Biological Method based Dodecanoic Acid (DC12) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Biological Method based Dodecanoic Acid (DC12) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Biological Method based Dodecanoic Acid (DC12) Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Biological Method based Dodecanoic Acid (DC12) Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Biological Method based Dodecanoic Acid (DC12) Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 7. Global Biological Method based Dodecanoic Acid (DC12) Sales by Region (2020-2025) & (Tons)
 Table 8. Global Biological Method based Dodecanoic Acid (DC12) Sales by Region (2026-2031) & (Tons)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Biological Method based Dodecanoic Acid (DC12) Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 11. Global Biological Method based Dodecanoic Acid (DC12) Production by Region (2020-2025) & (Tons)
 Table 12. Global Biological Method based Dodecanoic Acid (DC12) Production by Region (2026-2031) & (Tons)
 Table 13. Global Biological Method based Dodecanoic Acid (DC12) Sales by Manufacturers (2020-2025) & (Tons)
 Table 14. Global Biological Method based Dodecanoic Acid (DC12) Sales Share by Manufacturers (2020-2025)
 Table 15. Global Biological Method based Dodecanoic Acid (DC12) Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 16. Global Biological Method based Dodecanoic Acid (DC12) Revenue Market Share by Manufacturers (2020-2025)
 Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 18. Global Biological Method based Dodecanoic Acid (DC12) by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biological Method based Dodecanoic Acid (DC12) as of 2024)
 Table 19. Global Biological Method based Dodecanoic Acid (DC12) Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 20. Global Biological Method based Dodecanoic Acid (DC12) Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
 Table 21. Key Manufacturers Biological Method based Dodecanoic Acid (DC12) Manufacturing Base and Headquarters
 Table 22. Global Biological Method based Dodecanoic Acid (DC12) Market Concentration Ratio (CR5 and HHI)
 Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 25. Global Biological Method based Dodecanoic Acid (DC12) Sales by Type (2020-2025) & (Tons)
 Table 26. Global Biological Method based Dodecanoic Acid (DC12) Sales by Type (2026-2031) & (Tons)
 Table 27. Global Biological Method based Dodecanoic Acid (DC12) Revenue by Type (2020-2025) & (US$ Million)
 Table 28. Global Biological Method based Dodecanoic Acid (DC12) Revenue by Type (2026-2031) & (US$ Million)
 Table 29. Global Biological Method based Dodecanoic Acid (DC12) ASP by Type (2020-2031) & (US$/Ton)
 Table 30. Technical Specifications by Key Product Type
 Table 31. Global Biological Method based Dodecanoic Acid (DC12) Sales by Application (2020-2025) & (Tons)
 Table 32. Global Biological Method based Dodecanoic Acid (DC12) Sales by Application (2026-2031) & (Tons)
 Table 33. Biological Method based Dodecanoic Acid (DC12) High-Growth Sectors Demand CAGR (2024-2031)
 Table 34. Global Biological Method based Dodecanoic Acid (DC12) Revenue by Application (2020-2025) & (US$ Million)
 Table 35. Global Biological Method based Dodecanoic Acid (DC12) Revenue by Application (2026-2031) & (US$ Million)
 Table 36. Global Biological Method based Dodecanoic Acid (DC12) ASP by Application (2020-2031) & (US$/Ton)
 Table 37. Top Customers by Region
 Table 38. Top Customers by Application
 Table 39. North America Biological Method based Dodecanoic Acid (DC12) Growth Accelerators and Market Barriers
 Table 40. North America Biological Method based Dodecanoic Acid (DC12) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 41. North America Biological Method based Dodecanoic Acid (DC12) Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 42. Europe Biological Method based Dodecanoic Acid (DC12) Growth Accelerators and Market Barriers
 Table 43. Europe Biological Method based Dodecanoic Acid (DC12) Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 44. Europe Biological Method based Dodecanoic Acid (DC12) Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 45. Asia-Pacific Biological Method based Dodecanoic Acid (DC12) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Asia-Pacific Biological Method based Dodecanoic Acid (DC12) Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 47. Asia-Pacific Biological Method based Dodecanoic Acid (DC12) Growth Accelerators and Market Barriers
 Table 48. Southeast Asia Biological Method based Dodecanoic Acid (DC12) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 49. Central and South America Biological Method based Dodecanoic Acid (DC12) Investment Opportunities and Key Challenges
 Table 50. Central and South America Biological Method based Dodecanoic Acid (DC12) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 51. Middle East and Africa Biological Method based Dodecanoic Acid (DC12) Investment Opportunities and Key Challenges
 Table 52. Middle East and Africa Biological Method based Dodecanoic Acid (DC12) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 53. Cathay Biotech Corporation Information
 Table 54. Cathay Biotech Description and Major Businesses
 Table 55. Cathay Biotech Product Models, Descriptions and Specifications
 Table 56. Cathay Biotech Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 57. Cathay Biotech Sales Value Proportion by Product in 2024
 Table 58. Cathay Biotech Sales Value Proportion by Application in 2024
 Table 59. Cathay Biotech Sales Value Proportion by Geographic Area in 2024
 Table 60. Cathay Biotech Biological Method based Dodecanoic Acid (DC12) SWOT Analysis
 Table 61. Cathay Biotech Recent Developments
 Table 62. INVISTA Corporation Information
 Table 63. INVISTA Description and Major Businesses
 Table 64. INVISTA Product Models, Descriptions and Specifications
 Table 65. INVISTA Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 66. INVISTA Sales Value Proportion by Product in 2024
 Table 67. INVISTA Sales Value Proportion by Application in 2024
 Table 68. INVISTA Sales Value Proportion by Geographic Area in 2024
 Table 69. INVISTA Biological Method based Dodecanoic Acid (DC12) SWOT Analysis
 Table 70. INVISTA Recent Developments
 Table 71. Evonik Industries Corporation Information
 Table 72. Evonik Industries Description and Major Businesses
 Table 73. Evonik Industries Product Models, Descriptions and Specifications
 Table 74. Evonik Industries Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 75. Evonik Industries Sales Value Proportion by Product in 2024
 Table 76. Evonik Industries Sales Value Proportion by Application in 2024
 Table 77. Evonik Industries Sales Value Proportion by Geographic Area in 2024
 Table 78. Evonik Industries Biological Method based Dodecanoic Acid (DC12) SWOT Analysis
 Table 79. Evonik Industries Recent Developments
 Table 80. UBE Industries Corporation Information
 Table 81. UBE Industries Description and Major Businesses
 Table 82. UBE Industries Product Models, Descriptions and Specifications
 Table 83. UBE Industries Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 84. UBE Industries Sales Value Proportion by Product in 2024
 Table 85. UBE Industries Sales Value Proportion by Application in 2024
 Table 86. UBE Industries Sales Value Proportion by Geographic Area in 2024
 Table 87. UBE Industries Biological Method based Dodecanoic Acid (DC12) SWOT Analysis
 Table 88. UBE Industries Recent Developments
 Table 89. Palmary Chemical Corporation Information
 Table 90. Palmary Chemical Description and Major Businesses
 Table 91. Palmary Chemical Product Models, Descriptions and Specifications
 Table 92. Palmary Chemical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. Palmary Chemical Sales Value Proportion by Product in 2024
 Table 94. Palmary Chemical Sales Value Proportion by Application in 2024
 Table 95. Palmary Chemical Sales Value Proportion by Geographic Area in 2024
 Table 96. Palmary Chemical Biological Method based Dodecanoic Acid (DC12) SWOT Analysis
 Table 97. Palmary Chemical Recent Developments
 Table 98. Henan Junheng Industrial Group Corporation Information
 Table 99. Henan Junheng Industrial Group Description and Major Businesses
 Table 100. Henan Junheng Industrial Group Product Models, Descriptions and Specifications
 Table 101. Henan Junheng Industrial Group Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 102. Henan Junheng Industrial Group Recent Developments
 Table 103. Shandong Guangtong New Materials Corporation Information
 Table 104. Shandong Guangtong New Materials Description and Major Businesses
 Table 105. Shandong Guangtong New Materials Product Models, Descriptions and Specifications
 Table 106. Shandong Guangtong New Materials Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 107. Shandong Guangtong New Materials Recent Developments
 Table 108. Hengli Biological New Materials Corporation Information
 Table 109. Hengli Biological New Materials Description and Major Businesses
 Table 110. Hengli Biological New Materials Product Models, Descriptions and Specifications
 Table 111. Hengli Biological New Materials Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 112. Hengli Biological New Materials Recent Developments
 Table 113. Key Raw Materials Distribution
 Table 114. Raw Materials Key Suppliers
 Table 115. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 116. Milestones in Production Technology Evolution
 Table 117. Distributors List
 Table 118. Market Trends and Market Evolution
 Table 119. Market Drivers and Opportunities
 Table 120. Market Challenges, Risks, and Restraints
 Table 121. Research Programs/Design for This Report
 Table 122. Key Data Information from Secondary Sources
 Table 123. Key Data Information from Primary Sources


List of Figures
 Figure 1. Biological Method based Dodecanoic Acid (DC12) Product Picture
 Figure 2. Global Biological Method based Dodecanoic Acid (DC12) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. ≥98.5% Product Picture
 Figure 4. ≥95% Product Picture
 Figure 5. Global Biological Method based Dodecanoic Acid (DC12) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Polyamide and Polyester Resin
 Figure 7. Metal Processing
 Figure 8. Spices
 Figure 9. Other
 Figure 10. Biological Method based Dodecanoic Acid (DC12) Report Years Considered
 Figure 11. Global Biological Method based Dodecanoic Acid (DC12) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Biological Method based Dodecanoic Acid (DC12) Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Biological Method based Dodecanoic Acid (DC12) Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Biological Method based Dodecanoic Acid (DC12) Revenue Market Share by Region (2020-2031)
 Figure 15. Global Biological Method based Dodecanoic Acid (DC12) Sales (2020-2031) & (Tons)
 Figure 16. Global Biological Method based Dodecanoic Acid (DC12) Sales (CAGR) by Region (2020-2031) (Tons)
 Figure 17. Global Biological Method based Dodecanoic Acid (DC12) Sales Market Share by Region (2020-2031)
 Figure 18. Global Biological Method based Dodecanoic Acid (DC12) Capacity, Production and Utilization (2020-2031) & (Tons)
 Figure 19. Global Biological Method based Dodecanoic Acid (DC12) Production Trend by Region (2020-2031) (Tons)
 Figure 20. Global Biological Method based Dodecanoic Acid (DC12) Production Market Share by Region (2020-2031)
 Figure 21. Production Capacity Enablers & Constraints
 Figure 22. Biological Method based Dodecanoic Acid (DC12) Production Growth Rate in North America (2020-2031) & (Tons)
 Figure 23. Biological Method based Dodecanoic Acid (DC12) Production Growth Rate in Europe (2020-2031) & (Tons)
 Figure 24. Biological Method based Dodecanoic Acid (DC12) Production Growth Rate in China (2020-2031) & (Tons)
 Figure 25. Biological Method based Dodecanoic Acid (DC12) Production Growth Rate in Japan (2020-2031) & (Tons)
 Figure 26. Top 5 and Top 10 Manufacturers Biological Method based Dodecanoic Acid (DC12) Sales Volume Market Share in 2024
 Figure 27. Global Biological Method based Dodecanoic Acid (DC12) Revenue Market Share Ranking (2024)
 Figure 28. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 29. ≥98.5% Revenue Market Share by Manufacturer in 2024
 Figure 30. ≥95% Revenue Market Share by Manufacturer in 2024
 Figure 31. Type Eight Revenue Market Share by Manufacturer in 2024
 Figure 32. Type Nine Revenue Market Share by Manufacturer in 2024
 Figure 33. Global Biological Method based Dodecanoic Acid (DC12) Sales Market Share by Type (2020-2031)
 Figure 34. Global Biological Method based Dodecanoic Acid (DC12) Revenue Market Share by Type (2020-2031)
 Figure 35. Global Biological Method based Dodecanoic Acid (DC12) Sales Market Share by Application (2020-2031)
 Figure 36. Global Biological Method based Dodecanoic Acid (DC12) Revenue Market Share by Application (2020-2031)
 Figure 37. North America Biological Method based Dodecanoic Acid (DC12) Sales YoY (2020-2031) & (Tons)
 Figure 38. North America Biological Method based Dodecanoic Acid (DC12) Revenue YoY (2020-2031) & (US$ Million)
 Figure 39. North America Top 5 Manufacturers Biological Method based Dodecanoic Acid (DC12) Sales Revenue (US$ Million) in 2024
 Figure 40. North America Biological Method based Dodecanoic Acid (DC12) Sales Volume (Tons) by Type (2020- 2031)
 Figure 41. North America Biological Method based Dodecanoic Acid (DC12) Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 42. North America Biological Method based Dodecanoic Acid (DC12) Sales Volume (Tons) by Application (2020-2031)
 Figure 43. North America Biological Method based Dodecanoic Acid (DC12) Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 44. US Biological Method based Dodecanoic Acid (DC12) Revenue (2020-2031) & (US$ Million)
 Figure 45. Canada Biological Method based Dodecanoic Acid (DC12) Revenue (2020-2031) & (US$ Million)
 Figure 46. Mexico Biological Method based Dodecanoic Acid (DC12) Revenue (2020-2031) & (US$ Million)
 Figure 47. Europe Biological Method based Dodecanoic Acid (DC12) Sales YoY (2020-2031) & (Tons)
 Figure 48. Europe Biological Method based Dodecanoic Acid (DC12) Revenue YoY (2020-2031) & (US$ Million)
 Figure 49. Europe Top 5 Manufacturers Biological Method based Dodecanoic Acid (DC12) Sales Revenue (US$ Million) in 2024
 Figure 50. Europe Biological Method based Dodecanoic Acid (DC12) Sales Volume (Tons) by Type (2020-2031)
 Figure 51. Europe Biological Method based Dodecanoic Acid (DC12) Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 52. Europe Biological Method based Dodecanoic Acid (DC12) Sales Volume (Tons) by Application (2020-2031)
 Figure 53. Europe Biological Method based Dodecanoic Acid (DC12) Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 54. Germany Biological Method based Dodecanoic Acid (DC12) Revenue (2020-2031) & (US$ Million)
 Figure 55. France Biological Method based Dodecanoic Acid (DC12) Revenue (2020-2031) & (US$ Million)
 Figure 56. U.K. Biological Method based Dodecanoic Acid (DC12) Revenue (2020-2031) & (US$ Million)
 Figure 57. Italy Biological Method based Dodecanoic Acid (DC12) Revenue (2020-2031) & (US$ Million)
 Figure 58. Russia Biological Method based Dodecanoic Acid (DC12) Revenue (2020-2031) & (US$ Million)
 Figure 59. Asia-Pacific Biological Method based Dodecanoic Acid (DC12) Sales YoY (2020-2031) & (Tons)
 Figure 60. Asia-Pacific Biological Method based Dodecanoic Acid (DC12) Revenue YoY (2020-2031) & (US$ Million)
 Figure 61. Asia-Pacific Top 8 Manufacturers Biological Method based Dodecanoic Acid (DC12) Sales Revenue (US$ Million) in 2024
 Figure 62. Asia-Pacific Biological Method based Dodecanoic Acid (DC12) Sales Volume (Tons) by Type (2020- 2031)
 Figure 63. Asia-Pacific Biological Method based Dodecanoic Acid (DC12) Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 64. Asia-Pacific Biological Method based Dodecanoic Acid (DC12) Sales Volume (Tons) by Application (2020-2031)
 Figure 65. Asia-Pacific Biological Method based Dodecanoic Acid (DC12) Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 66. Indonesia Biological Method based Dodecanoic Acid (DC12) Revenue (2020-2031) & (US$ Million)
 Figure 67. Japan Biological Method based Dodecanoic Acid (DC12) Revenue (2020-2031) & (US$ Million)
 Figure 68. South Korea Biological Method based Dodecanoic Acid (DC12) Revenue (2020-2031) & (US$ Million)
 Figure 69. China Taiwan Biological Method based Dodecanoic Acid (DC12) Revenue (2020-2031) & (US$ Million)
 Figure 70. India Biological Method based Dodecanoic Acid (DC12) Revenue (2020-2031) & (US$ Million)
 Figure 71. Central and South America Biological Method based Dodecanoic Acid (DC12) Sales YoY (2020-2031) & (Tons)
 Figure 72. Central and South America Biological Method based Dodecanoic Acid (DC12) Revenue YoY (2020-2031) & (US$ Million)
 Figure 73. Central and South America Top 5 Manufacturers Biological Method based Dodecanoic Acid (DC12) Sales Revenue (US$ Million) in 2024
 Figure 74. Central and South America Biological Method based Dodecanoic Acid (DC12) Sales Volume (Tons) by Type (2021-2031)
 Figure 75. Central and South America Biological Method based Dodecanoic Acid (DC12) Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 76. Central and South America Biological Method based Dodecanoic Acid (DC12) Sales Volume (Tons) by Application (2020-2031)
 Figure 77. Central and South America Biological Method based Dodecanoic Acid (DC12) Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 78. Brazil Biological Method based Dodecanoic Acid (DC12) Revenue (2020-2025) & (US$ Million)
 Figure 79. Argentina Biological Method based Dodecanoic Acid (DC12) Revenue (2020-2025) & (US$ Million)
 Figure 80. Middle East, and Africa Biological Method based Dodecanoic Acid (DC12) Sales YoY (2020-2031) & (Tons)
 Figure 81. Middle East and Africa Biological Method based Dodecanoic Acid (DC12) Revenue YoY (2020-2031) & (US$ Million)
 Figure 82. Middle East and Africa Top 5 Manufacturers Biological Method based Dodecanoic Acid (DC12) Sales Revenue (US$ Million) in 2024
 Figure 83. Middle East and Africa Biological Method based Dodecanoic Acid (DC12) Sales Volume (Tons) by Type (2021-2031)
 Figure 84. South America Biological Method based Dodecanoic Acid (DC12) Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 85. Middle East and Africa Biological Method based Dodecanoic Acid (DC12) Sales Volume (Tons) by Application (2020-2031)
 Figure 86. Middle East and Africa Biological Method based Dodecanoic Acid (DC12) Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 87. GCC Countries Biological Method based Dodecanoic Acid (DC12) Revenue (2020-2025) & (US$ Million)
 Figure 88. Turkey Biological Method based Dodecanoic Acid (DC12) Revenue (2020-2025) & (US$ Million)
 Figure 89. Egypt Biological Method based Dodecanoic Acid (DC12) Revenue (2020-2025) & (US$ Million)
 Figure 90. South Africa Biological Method based Dodecanoic Acid (DC12) Revenue (2020-2025) & (US$ Million)
 Figure 91. Biological Method based Dodecanoic Acid (DC12) Industry Chain Mapping
 Figure 92. Regional Biological Method based Dodecanoic Acid (DC12) Manufacturing Base Distribution (%)
 Figure 93. Biological Method based Dodecanoic Acid (DC12) Production Process
 Figure 94. Regional Biological Method based Dodecanoic Acid (DC12) Production Cost Structure
 Figure 95. Channels of Distribution (Direct Vs Distribution)
 Figure 96. Bottom-up and Top-down Approaches for This Report
 Figure 97. Data Triangulation
 Figure 98. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

RELATED REPORTS

Global Resorcinol Formaldehyde Adhesive Resin Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19T20220
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Low-Sludge Phosphating Solution Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33H20007
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Linear Alpha-Olefin Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5Y6896
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Nodulizer Cored Wire Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10G20315
Wed Dec 03 00:00:00 UTC 2025

Add to Cart